Two new appointments at Cerulean Pharma
This article was originally published in Scrip
Cerulean Pharma, a US biopharmaceutical company focused on nanoparticle-based drugs, has appointed Dr John Ryan senior vice-president and chief medical officer and Karen Roberts senior vice-president of finance and administration. Dr Ryan has more than 20 years' experience in clinical research and development at AVEO Pharmaceuticals, Wyeth (formerly Genetics Institute) and Merck Research Laboratories. He most recently served as chief medical officer at AVEO, where he built a clinical group for the development of oncology drugs. Ms Roberts joins from Elixir Pharmaceuticals, where she previously served as vice-president of finance and administration.